Work

Enabling equitable open access to commercially funded research publications

Year: 2026

Type: article

Abstract: Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such as funder-neutral publishing policies, will help address this inequity.

Source: PLoS Medicine

DOI: 10.1371/journal.pmed.1005207

Authors: Anja Schmidt, Christopher C. Winchester, Catherine Skobe, Diane R. Stothard, Eric Topol

Institutions: Pfizer (United States), Eli Lilly (United States)

Language: English

Topic: Academic Publishing and Open Access

Subfield: Information Systems and Management

Field: Decision Sciences

Domain: Social Sciences

SDG: Reduced inequalities

Open Access status: gold

Estimated APC paid: $6,460